Changeflow GovPing Environment Pendimethalin Data Call-In and EDSP Studies
Priority review Rule Added Final

Pendimethalin Data Call-In and EDSP Studies

Email

Summary

The EPA issued a data call-in requiring registrants of pendimethalin pesticide products to submit Endocrine Disruptor Screening Program (EDSP) studies. Affected parties must provide specific toxicology and exposure data to support EPA's evaluation of potential endocrine-disrupting effects. Non-compliance with this data call-in may result in regulatory consequences including registration suspension or cancellation.

What changed

The EPA has issued a data call-in under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) requiring registrants of pendimethalin-containing pesticide products to generate and submit Endocrine Disruptor Screening Program studies. This mandate obligates registrants to conduct and submit specific toxicology data to support EPA's ongoing review of potential endocrine-disrupting effects of pendimethalin.

Registrants with pendimethalin products face immediate compliance obligations to initiate required studies and submit data within EPA's specified timeline. Failure to respond to this data call-in may result in EPA initiating registration review procedures, including potential suspension or cancellation of affected product registrations. Companies should review their pendimethalin product portfolios and allocate resources for required EDSP study generation.

What to do next

  1. Submit required EDSP studies to EPA by the specified deadline
  2. Review all pendimethalin product registrations for affected data requirements
  3. Contact EPA if unable to meet data submission timeline

Penalties

Registration suspension or cancellation for failure to comply with data call-in requirements

Archived snapshot

Apr 8, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Content

Download File

Download

Named provisions

Endocrine Disruptor Screening Program Data Call-In Requirements

Get daily alerts for Regs.gov: Environmental Protection Agency

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPA.

What's AI-generated?

The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.

Last updated

Classification

Agency
EPA
Instrument
Rule
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
EPA-HQ-OPP-2012-0219-0039
Docket
EPA-HQ-OPP-2012-0219

Who this affects

Applies to
Drug manufacturers Government agencies Manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Pesticide registration Endocrine disruptor testing Toxicology data submission
Geographic scope
United States US

Taxonomy

Primary area
Agriculture
Operational domain
Regulatory Affairs
Compliance frameworks
GxP
Topics
Environmental Protection Public Health

Get alerts for this source

We'll email you when Regs.gov: Environmental Protection Agency publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.